BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35833788)

  • 1. Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID-19 pandemic: a report from Australia and New Zealand transplant and cellular therapies.
    Othman J; Aarons D; Bajel A; Butler J; Doocey R; O'Brien T; Purtill D; Smith L; Wilcox L; Hamad N
    Intern Med J; 2023 Mar; 53(3):323-329. PubMed ID: 35833788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
    Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Szer J
    Intern Med J; 2005 Jan; 35(1):18-27. PubMed ID: 15667464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemopoietic stem cell transplantation for children in Australia and New Zealand, 1998-2006: a report on behalf of the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group.
    Moore AS; Shaw PJ; Hallahan AR; Carter TL; Kilo T; Nivison-Smith I; O'Brien TA; Tapp H; Teague L; Wilson SR; Tiedemann K
    Med J Aust; 2009 Feb; 190(3):121-5. PubMed ID: 19203307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
    Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM
    Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemopoietic stem cell transplantation in Australia, 1992-95: a report from the Australian Bone Marrow Transplant Recipient Registry.
    Atkinson K; Nivison-Smith I; Hawkins T
    Aust N Z J Med; 1997 Aug; 27(4):408-19. PubMed ID: 9448882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis.
    Allan DS; Green M; Morris G; Weiss J; Dibdin N; Mercer D; Seftel M
    Vox Sang; 2022 Sep; 117(9):1121-1125. PubMed ID: 35583125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program.
    Farhadfar N; Newman J; Novakovich J; Barten J; Ndifon ET; Oakes J; Cody M; Pham HP; Auletta JJ; Miller JP; Devine SM; Stefanski HE
    Front Immunol; 2022; 13():937900. PubMed ID: 36203566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal.
    Valentini CG; Chiusolo P; Bianchi M; Metafuni E; Orlando N; Giammarco S; Bacigalupo A; Sica S; Teofili L
    Cytotherapy; 2021 Jul; 23(7):635-640. PubMed ID: 33423867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.
    Perram J; Purtill D; Bajel A; Butler J; O'Brien T; Teh B; Gilroy N; Ho PJ; Doocey R; Hills T; Perera T; Douglas G; Ramachandran S; Chee L; Trotman J; Weinkove R; Keogh S; Fraser C; Cochrane T; Watson AM; Diamond P; Latimer M; Irving I; Blyth E; Cheah C; Cole T; Milliken S; Yang H; Greenwood M; Bardy P; Kennedy G; Larsen S; Conyers R; Hamad N
    Intern Med J; 2023 Jan; 53(1):119-125. PubMed ID: 36371767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic.
    Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N
    Transplant Cell Ther; 2021 Dec; 27(12):1022.e1-1022.e6. PubMed ID: 34571211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004.
    Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Ma DD; Moore JJ; Simpson JM; Szer J
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):905-12. PubMed ID: 17640594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experience.
    Nivison-Smith I; Bajel A; Dodds AJ; Gottlieb D; Hamad N; Kennedy G; Kerridge I; Ma DDF; Milliken S; Moore J; Purtill D; Szer J
    Intern Med J; 2022 Jan; 52(1):57-62. PubMed ID: 33131163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety.
    Parmar G; Allan DS; Morris G; Dibdin N; Ganz K; Mostert K; Paulson K; Petraszko T; Stevens N; Seftel MD
    Curr Oncol; 2023 Mar; 30(3):3549-3556. PubMed ID: 36975483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry.
    Patton WN; Nivison-Smith I; Bardy P; Dodds A; Ma D; Shaw PJ; Kwan J; Wilcox L; Butler A; Carter JM; Blacklock H; Szer J
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):147-152. PubMed ID: 27717872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis.
    Arnold SD; Brazauskas R; He N; Li Y; Hall M; Atsuta Y; Dalal J; Hahn T; Khera N; Bonfim C; Hashmi S; Parsons S; Wood WA; Steinberg A; Freytes CO; Dandoy CE; Marks DI; Lazarus HM; Abdel-Azim H; Bitan M; Diaz MA; Olsson RF; Gergis U; Seber A; Wirk B; LeMaistre CF; Ustun C; Duncan C; Rizzieri D; Szwajcer D; Fagioli F; Frangoul H; Knight JM; Kamble RT; Mehta P; Schears R; Satwani P; Pulsipher MA; Aplenc R; Saber W
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1747-1756. PubMed ID: 32464284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in Japan.
    Shimomura Y; Kitamura T; Nishikubo M; Sobue T; Uchida N; Doki N; Tanaka M; Ito A; Ishikawa J; Ara T; Ota S; Onizuka M; Sawa M; Ozawa Y; Maruyama Y; Ikegame K; Kanda Y; Ichinohe T; Fukuda T; Okamoto S; Teshima T; Atsuta Y
    Int J Hematol; 2023 Apr; 117(4):590-597. PubMed ID: 36515796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.
    Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR
    Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site.
    Wiercinska E; Schlipfenbacher V; Bug G; Bader P; Verbeek M; Seifried E; Bonig H
    J Transl Med; 2021 Apr; 19(1):145. PubMed ID: 33832504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.